The University of Chicago Header Logo

Connection

Christine Schmid-Tannwald to Humans

Back to Details
This is a "connection" page, showing publications Christine Schmid-Tannwald has written about Humans.
Christine Schmid-Tannwald
Connection Strength
0.519
Humans
  1. Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients. Radiol Oncol. 2024 09 01; 58(3):348-356.
    View in: PubMed
    Score: 0.028
  2. [Imaging of pancreatic neuroendocrine tumors]. Radiologie (Heidelb). 2024 Jul; 64(7):559-567.
    View in: PubMed
    Score: 0.028
  3. Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors. Radiol Oncol. 2024 06 01; 58(2):196-205.
    View in: PubMed
    Score: 0.028
  4. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases. Radiol Oncol. 2024 03 01; 58(1):33-42.
    View in: PubMed
    Score: 0.027
  5. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM. Radiol Oncol. 2023 12 01; 57(4):436-445.
    View in: PubMed
    Score: 0.027
  6. Diffusion-weighted imaging in Crohn's disease. Radiologie (Heidelb). 2023 Nov; 63(Suppl 2):27-33.
    View in: PubMed
    Score: 0.027
  7. Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT. Diagn Interv Imaging. 2024 Jan; 105(1):15-25.
    View in: PubMed
    Score: 0.026
  8. [Magnetic resonance enterography/enteroclysis : Technical aspects and indications]. Radiologie (Heidelb). 2023 Jun; 63(6):429-434.
    View in: PubMed
    Score: 0.026
  9. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol. 2022 Jul; 63(7):877-888.
    View in: PubMed
    Score: 0.023
  10. The role of diffusion-weighted MRI in assessment of inflammatory bowel disease. Abdom Radiol (NY). 2016 08; 41(8):1484-94.
    View in: PubMed
    Score: 0.016
  11. Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot Study. Technol Cancer Res Treat. 2015 Apr; 14(2):191-9.
    View in: PubMed
    Score: 0.014
  12. [Gastroenteropancreatic endocrine tumors]. Radiologe. 2014 Oct; 54(10):989-97.
    View in: PubMed
    Score: 0.014
  13. Role of diffusion-weighted MRI in differentiation of hepatic abscesses from non-infected fluid collections. Clin Radiol. 2014 Jul; 69(7):687-94.
    View in: PubMed
    Score: 0.014
  14. DW-MRI of liver lesions: can a single ADC-value represent the entire lesion? Clin Radiol. 2014 May; 69(5):492-8.
    View in: PubMed
    Score: 0.014
  15. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases? Acta Radiol. 2014 Jun; 55(5):515-23.
    View in: PubMed
    Score: 0.013
  16. Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values? Acad Radiol. 2013 Apr; 20(4):440-5.
    View in: PubMed
    Score: 0.013
  17. Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging. 2013 Jun; 40(6):897-907.
    View in: PubMed
    Score: 0.013
  18. Diffusion-weighted MRI of the abdomen: current value in clinical routine. J Magn Reson Imaging. 2013 Jan; 37(1):35-47.
    View in: PubMed
    Score: 0.013
  19. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate. Acta Radiol. 2012 Nov 01; 53(9):961-5.
    View in: PubMed
    Score: 0.012
  20. Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts. J Magn Reson Imaging. 2012 Jan; 35(1):125-31.
    View in: PubMed
    Score: 0.012
  21. Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board. Target Oncol. 2025 Jul; 20(4):715-724.
    View in: PubMed
    Score: 0.008
  22. [18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics. Eur J Nucl Med Mol Imaging. 2025 Nov; 52(13):5175-5188.
    View in: PubMed
    Score: 0.007
  23. Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics. 2025; 15(13):6444-6453.
    View in: PubMed
    Score: 0.007
  24. ECG, clinical and novel CT-imaging predictors of necessary pacemaker implantation after transfemoral aortic valve replacement. Eur J Radiol. 2025 Jan; 182:111835.
    View in: PubMed
    Score: 0.007
  25. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients. Eur Radiol. 2024 Feb; 34(2):1157-1166.
    View in: PubMed
    Score: 0.007
  26. Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs. Cancer Imaging. 2023 Apr 25; 23(1):41.
    View in: PubMed
    Score: 0.006
  27. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis. Eur J Radiol. 2023 Jun; 163:110803.
    View in: PubMed
    Score: 0.006
  28. Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients. Eur Radiol. 2023 May; 33(5):3416-3424.
    View in: PubMed
    Score: 0.006
  29. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma. Acta Radiol. 2024 Jan; 65(1):14-22.
    View in: PubMed
    Score: 0.006
  30. [HAND: HIV-associated dementia in a late presenter]. MMW Fortschr Med. 2022 06; 164(Suppl 2):63-65.
    View in: PubMed
    Score: 0.006
  31. Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment. Endocrine. 2020 11; 70(2):218-231.
    View in: PubMed
    Score: 0.005
  32. Injuries of the isolated larynx-hyoid complex in post-mortem computed tomography (PMCT) and post-mortem fine preparation (PMFP) - a comparison of 54 forensic cases. Eur Radiol. 2020 Aug; 30(8):4564-4572.
    View in: PubMed
    Score: 0.005
  33. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties? Radiat Oncol. 2016 Oct 21; 11(1):139.
    View in: PubMed
    Score: 0.004
  34. 18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis. J Nucl Med. 2017 04; 58(4):584-589.
    View in: PubMed
    Score: 0.004
  35. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense? J Nucl Med. 2016 08; 57(8):1177-82.
    View in: PubMed
    Score: 0.004
  36. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. Eur J Nucl Med Mol Imaging. 2016 Jun; 43(6):1105-14.
    View in: PubMed
    Score: 0.004
  37. Magnetic resonance enterography/enteroclysis in acquired small bowel diverticulitis and small bowel diverticulosis. Eur Radiol. 2016 Sep; 26(9):2881-91.
    View in: PubMed
    Score: 0.004
  38. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability. Invest Radiol. 2015 Jan; 50(1):57-66.
    View in: PubMed
    Score: 0.004
  39. Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. J Nucl Med. 2015 Jan; 56(1):9-15.
    View in: PubMed
    Score: 0.004
  40. Apparent diffusion coefficient for prostate cancer imaging: impact of B values. AJR Am J Roentgenol. 2014 Mar; 202(3):W247-53.
    View in: PubMed
    Score: 0.003
  41. Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. J Nucl Med. 2014 Feb; 55(2):198-203.
    View in: PubMed
    Score: 0.003
  42. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology. 2013 Jun; 267(3):797-806.
    View in: PubMed
    Score: 0.003
  43. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Radiology. 2013 Jun; 267(3):787-96.
    View in: PubMed
    Score: 0.003
  44. MR imaging of ectopic pregnancy with an emphasis on unusual implantation sites. Jpn J Radiol. 2013 Feb; 31(2):75-80.
    View in: PubMed
    Score: 0.003
  45. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011 Dec; 197(6):1382-90.
    View in: PubMed
    Score: 0.003
  46. Diffusion-weighted MR imaging of abdominopelvic abscesses. Emerg Radiol. 2011 Dec; 18(6):515-24.
    View in: PubMed
    Score: 0.003
  47. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol. 2010 Jan; 248(1):85-92.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.